![]() |
JOURNAL TOOLS |
Publishing options |
eTOC |
To subscribe |
Submit an article |
Recommend to your librarian |
ARTICLE TOOLS |
Reprints |
Permissions |
Share |


YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
REVIEWS CONCURRENT CAROTID REVASCULARIZATION AND CORONARY ARTERY BYPASS
Italian Journal of Vascular and Endovascular Surgery 2009 December;16(4):241-8
Copyright © 2010 EDIZIONI MINERVA MEDICA
language: English
Current management of asymptomatic carotid occlusive disease: a review
McEnaney R. M., Chaer R. A.
Division of Vascular Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
Cerebrovascular disease is a major cause of morbidity and disability worldwide, placing a large financial burden on health care systems. The majority of strokes are ischemic in nature. A significant portion these result from occlusive disease of the extracranial carotid artery. Treatment of asymptomatic patients identified with significant carotid artery disease is aimed at the prevention of stroke and its resultant morbidity. To this end, carotid endarterectomy has been established as the gold standard by several landmark trials. Carotid angioplasty and stenting, on the other hand, has been introduced as a minimally invasive alternative for these patients. However, the indications for its use in this patient population continue to be in flux as data from large controlled studies emerges. The purpose of this manuscript is to review current data regarding the use of both carotid angioplasty and stenting and endarterectomy as treatments for asymptomatic carotid occlusive disease.